Valuation Grifols, S.A.

Stocks

Market Closed - BME Other stock markets 16:36:46 18/06/2026 BST			After hours 18:03:06
9.008 ^EUR	+0.04%		9.040	+0.36%

06-15	Grifols Launches Fesilty in the U.S	CI
06-15	Grifols Launches Fesilty Blood Clotting Concentrate in US	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	9,783	6,557	9,231	5,681	6,538	5,505	-	-
Change	-	-32.97%	40.77%	-38.46%	15.08%	-15.8%	-	-
Enterprise Value (EV) ¹	16,478	15,716	18,568	14,868	15,356	13,904	13,583	13,134
Change	-	-4.63%	18.15%	-19.93%	3.28%	-9.45%	-2.31%	-3.3%
P/E	62.5x	34.7x	172x	39.8x	18.1x	11.9x	8.87x	6.43x
PBR	1.89x	1.19x	1.79x	1.06x	0.96x	1.03x	0.93x	0.7x
PEG	-	2.3x	-2.4x	0x	0x	0.4x	0.3x	0.2x
Capitalization / Revenue	1.98x	1.08x	1.4x	0.79x	0.87x	0.72x	0.67x	0.64x
EV / Revenue	3.34x	2.59x	2.82x	2.06x	2.04x	1.81x	1.66x	1.52x
EV / EBITDA	17.1x	12.9x	12.8x	8.36x	8.41x	7.31x	6.41x	5.66x
EV / EBIT	27.7x	19.5x	18.1x	11x	11x	9.74x	8.35x	7.27x
EV / FCF	52.1x	-56.7x	-213x	28x	32.8x	27x	19.2x	15.7x
FCF Yield	1.92%	-1.76%	-0.47%	3.57%	3.05%	3.71%	5.21%	6.36%
Dividend per Share ²	0.36	-	-	-	-	0.2552	0.2951	0.4119
Rate of return	2.13%	-	-	-	-	2.83%	3.28%	4.57%
EPS ²	0.27	0.31	0.09	0.23	0.59	0.7582	1.015	1.399
Distribution rate	133%	-	-	-	-	33.7%	29.1%	29.4%
Net sales ¹	4,933	6,064	6,592	7,212	7,524	7,680	8,180	8,663
EBITDA ¹	961.5	1,221	1,455	1,779	1,825	1,901	2,118	2,319
EBIT ¹	595.1	805.7	1,023	1,357	1,391	1,427	1,626	1,807
Net income ¹	182.8	208.3	59.32	156.9	401.9	509.8	689.5	837.2
Net Debt ¹	6,695	9,158	9,337	9,187	8,818	8,399	8,078	7,629
Reference price ²	16.875	10.770	15.455	9.148	10.700	9.004	9.004	9.004
Nbr of stocks (in thousands)	682,484	678,911	678,665	679,629	680,509	680,575	-	-
Announcement Date	28/02/22	28/02/23	28/02/24	26/02/25	26/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GRIFOLS, S.A.	11.88x	1.81x	7.31x	2.83%	6.38B
REGENERON PHARMACEUTICALS, INC.	15.74x	3.4x	9.16x	0.65%	61.85B
UCB	27.21x	5.51x	16.1x	0.58%	55.69B
SAMSUNG BIOLOGICS CO.,LTD.	33.87x	11.46x	21.63x	-.--%	41.88B
CSL LIMITED	-48.56x	2.93x	8.64x	3.77%	36.15B
BIOGEN INC.	32.08x	3.48x	10.5x	-.--%	29.33B
MODERNA, INC.	-7.15x	10.01x	-6.12x	-.--%	24.52B
INCYTE CORPORATION	15.13x	2.63x	8.13x	-.--%	19.78B
INNOVENT BIOLOGICS, INC.	48.01x	5.09x	36.53x	-.--%	16.61B
SWEDISH ORPHAN BIOVITRUM AB	24.65x	5.1x	13.76x	-.--%	16.2B
Average	15.29x	5.14x	12.57x	0.78%	30.84B
Weighted average by Cap.	14.56x	5.45x	12.57x	0.74%